
ARA-290 10mg
$58.00
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to selectively engage tissue-protective signaling pathways without stimulating erythropoiesis. Classified as a non-hematopoietic EPO mimetic, ARA-290 has emerged as a significant research compound in studies focused on cellular repair, inflammatory regulation, neuroprotection, and tissue resilience.
Unlike full-length erythropoietin, which primarily influences red blood cell production through activation of the classical erythropoietin receptor, ARA-290 is designed to selectively interact with the innate repair receptor (IRR), a specialized receptor complex involved in cellular protection and regenerative signaling. This targeted mechanism allows researchers to investigate the biological effects of EPO-derived tissue repair pathways while avoiding the hematological activity associated with traditional erythropoietin signaling.
Preclinical studies have explored ARA-290's role in modulating inflammatory responses, supporting cellular recovery following injury, and promoting tissue homeostasis under conditions of physiological stress. Research suggests that activation of innate repair receptor pathways may influence processes related to cellular survival, neuroprotection, microvascular function, and the restoration of normal tissue architecture following damage.
Due to its unique mechanism of action, ARA-290 has attracted interest across multiple research disciplines, including neurology, regenerative medicine, immunology, and metabolic science. Investigators have utilized the peptide to study mechanisms associated with neuropathic conditions, inflammatory signaling, tissue injury, and the broader cellular pathways involved in recovery and adaptation.
As scientific understanding of endogenous repair systems continues to advance, ARA-290 remains an important tool for exploring the intersection of inflammation, cellular protection, and regenerative biology. Its selective engagement of innate repair receptor pathways has established it as a compelling compound for investigating the molecular mechanisms that support tissue resilience and long-term cellular health.
CAS NO: 1208243-50-8
Molecular Formula: C51H84N16O21
Molecular Weight: 1257.3 g/mol
Appearance: White Powder
Research Use Only
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Legal Disclaimer
This product and any associated information have not been evaluated by the U.S. Food and Drug Administration (FDA). No representations or warranties are made regarding its use for the diagnosis, treatment, cure, or prevention of any disease. Use is strictly limited to qualified professionals operating in properly equipped and certified laboratory environments.
Terms of Sale
By purchasing from Cutting Edge Compounds, the buyer certifies that they are a qualified researcher or represent a licensed institution. The buyer assumes full responsibility for ensuring compliance with all applicable laws and regulations governing the purchase, handling, storage, and use of this product. All sales are final.
STRENGHT | BATCH/LOT | RECEIVED | PURITY (%) | COA |
10mg | CEC-ARA-10-01 | April 2026 | 99.9% |
|---|
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Cutting Edge Compounds
We take pride in delivering high-quality research products you can trust. All of our products are made using premium-grade ingredients and undergo rigorous testing to ensure purity, potency, and consistency.
Contact
Helpful links
support@cuttingedgecompounds.com
MAILING ADDRESS
19510 Van Buren Blvd #F3-292
Riverside, Ca 92508


Please note that all products featured on this website are intended strictly for research and development purposes only. They are not designed for human consumption. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Cutting Edge Compounds operates solely as a chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B of the same act.
©2024 Cutting Edge Compounds · All Rights Reserved
